Trials / Completed
CompletedNCT01118325
An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease
A Randomised, Double-Blind, Parallel Group, Asian, Multicenter Study, to Assess Pharmacokinetic and Pharmacodynamic Profile of 2 Doses of Ticagrelor on Top of Low Dose Acetyl Salicylic Acid (ASA) Therapy on Platelet Aggregation in Japanese and Asian Patients With Stable Coronary Artery Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 146 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine the drug characteristics of Ticagrelor, and to determine if 4 weeks treatment will reduce the blood clotting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ticagrelor | Drug oral treatment |
| DRUG | clopidogrel | Drug oral treatment |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2010-05-06
- Last updated
- 2014-07-08
- Results posted
- 2012-04-09
Locations
13 sites across 2 countries: Japan, Philippines
Source: ClinicalTrials.gov record NCT01118325. Inclusion in this directory is not an endorsement.